Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

By sjmartinez • September 8, 2023

Murthy V, Gafita A, Thin P, Nguyen K, Grogan T, Shen J, Drakaki A, Rettig M, Czernin J, Calais J. Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with ¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. J Nucl Med. 2023 Sep 7:jnumed.122.265155. doi: 10.2967/jnumed.122.265155. Epub ahead of print. PMID: 37678927.

Tags: 177Lu-PSMA, Cardiology/Epi, end-of-treatment PET, Hematology/Oncology, metastatic castration-resistant prostate cancer, PSMA-PET, Publications, radioligand therapy

Demographics and Trends of Sudden Cardiac Death-Related Mortality in the United States, 1999 to 2022

Jaiswal V, Kumar D, Mashkoor Y, Latif F, Kanagala SG, Halder A, Jaiswal A, Bandyopadhyay D, Hajra A, Joshi A, Aronow WS, Fonarow GC. Demographics[...]

Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes

Yan AR, Srivastava PK, Vucicevic D, Agarwal MA, Ziaeian B, Fonarow GC, Nsair A, Shahandeh N. Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes.[...]

Skin-adaptive focused flexible micromachined ultrasound transducers for wearable cardiovascular health monitoring

Yuan J, Li Z, Zhao Y, Luo R, Qin S, Li J, Li M, Han G, Li Z, Zhao Z, Li J, Zhang S, Yuan[...]